Akorn Inc recalls Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10 Prescription Packs,…
- Recall date
- June 7, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1392-2019
- FDA classification
- Class III
- Brand / firm
- Akorn Inc
- Sold / distributed
- Nationwide USA
Why it was recalled
Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10 Prescription Packs, Rx Only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forest, IL 60045, NDC 61748-304-13
Get recall alerts
Free email alert whenever Akorn Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Akorn Inc